A detailed history of Lindbrook Capital, LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 911 shares of MDXG stock, worth $8,882. This represents 0.0% of its overall portfolio holdings.

Number of Shares
911
Previous 911 -0.0%
Holding current value
$8,882
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$6.16 - $8.08 $36 - $48
-6 Reduced 0.65%
911 $6,000
Q1 2024

Apr 25, 2024

BUY
$7.61 - $8.63 $45 - $51
6 Added 0.66%
917 $7,000
Q4 2022

Jan 24, 2023

BUY
$2.63 - $3.45 $2,395 - $3,142
911 New
911 $0
Q2 2022

Aug 01, 2022

SELL
$3.17 - $5.0 $1,483 - $2,340
-468 Reduced 87.97%
64 $0
Q1 2022

Apr 21, 2022

BUY
$4.27 - $6.27 $2,271 - $3,335
532 New
532 $3,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.11B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.